|
Market Closed -
Nasdaq
01:30:00 10/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 55.81 USD | +5.62% |
|
+1.22% | +41.08% |
| 25/09 | Atricure Insider Sold Shares Worth $271,140, According to a Recent SEC Filing | MT |
| 21/09 | AtriCure, Inc.(NasdaqGM:ATRC) added to S&P 1000 | CI |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 2,839 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | 44.34% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 2,687 | 2,612 | 2,518 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | 43.48% | -2.78% | -3.61% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 522x | 133x | 80.2x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 4.9x | 4.37x | 3.82x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -4x | 0x | 1.2x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 4.68x | 4.18x | 3.71x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 4.43x | 3.84x | 3.29x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 30.7x | 25.7x | 20.3x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 234x | 105x | 59.2x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 51x | 64.3x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 1.96% | 1.55% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.1068 | 0.4206 | 0.6961 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 606.3 | 679.7 | 765.4 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 87.49 | 101.7 | 124.2 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 11.46 | 24.98 | 42.55 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 7.132 | 20.89 | 35.25 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -151.9 | -226.6 | -320.8 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 55.81 | 55.81 | 55.81 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,866 | - | - |
| Announcement Date | 15/02/22 | 21/02/23 | 15/02/24 | 12/02/25 | 17/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 522.42x | 4.43x | 30.71x | -.--% | 283.88Cr | |
| 29.16x | 3.91x | 15.12x | 2.58% | 17TCr | |
| 18.92x | 3.45x | 12.33x | 3.18% | 11TCr | |
| 21.59x | 4.24x | 14.82x | 1.3% | 11TCr | |
| 25.92x | 2.55x | 10.24x | 2.77% | 7.53TCr | |
| 17.73x | 0.21x | 12.94x | 0.73% | 6.18TCr | |
| 30.68x | 7.58x | 19.64x | 1.3% | 5.29TCr | |
| 35.41x | 3.42x | 11.72x | 2.14% | 5.01TCr | |
| 35.08x | 8.72x | 24.53x | -.--% | 4.08TCr | |
| 33.8x | 5.92x | 18.59x | -.--% | 3.17TCr | |
| Average | 77.07x | 4.44x | 17.06x | 1.4% | 7.07TCr | |
| Weighted average by Cap. | 28.12x | 4.03x | 14.78x | 1.94% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
